Endosialin expression in relation to clinicopathological and biological variables in rectal cancers with a Swedish clinical trial of preoperative radiotherapy

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Zhang, Zhi Yong ^a,b,c   Zhang, Hong ^d   Adell, Gunnar ^e   Sun, Xiao Feng ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b TANGSHAN GONGREN HOSPITAL   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF SKÖVDE   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; ENDOSIALIN; PHOSPHATE; PHOSPHATE OF REGENERATING LIVER; PROTEIN P73; UNCLASSIFIED DRUG; CD248 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE RADIOTHERAPY; PROTEIN EXPRESSION; RADIATION RESPONSE; RECTUM CANCER; RECTUM MUCOSA; RECTUM SURGERY; TUMOR CELL; ADJUVANT THERAPY; CARCINOMA; CLINICAL TRIAL (TOPIC); DISEASE COURSE; EVALUATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREOPERATIVE PERIOD; PROGNOSIS; RECTUM TUMOR; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, NEOPLASM; CARCINOMA; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE PERIOD; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SWEDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 79952089288     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-89     Document Type: Article

References (34)

1. Cancer incidence in Sweden. 1997, The National Board of Health and Welfare.
2. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993, 341(8843):457-460. 10.1016/0140-6736(93)90207-W, 8094488.
3. Swedish rectal cancer trial Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997, 336(14):980-987. 10.1056/NEJM199704033361402, 9091798, Swedish rectal cancer trial.
4. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001, 264(1):169-184. 10.1006/excr.2000.5133, 11237532.
5. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432(7015):332-337. 10.1038/nature03096, 3050735, 15549095.
6. Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Jaffe EA, Old LJ. Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc Nat Acad Sci USA 1992, 89(22):10832-10836. 10.1073/pnas.89.22.10832, 50436, 1438285.
7. Christian S, Ahorn H, Koehler A, Eisenhaber F, Rodi HP, Garin-Chesa P, Park JE, Rettig WJ, Lenter MC. Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium. J Biol Chem 2001, 276(10):7408-7414. 10.1074/jbc.M009604200, 11084048.
8. Opavsky R, Haviernik P, Jurkovicova D, Garin MT, Copeland NG, Gilbert DJ, Jenkins NA, Bies J, Garfield S, Pastorekova S. Molecular characterization of the mouse Tem1/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo. J Biol Chem 2001, 276(42):38795-38807. 10.1074/jbc.M105241200, 11489895.
9. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, et al. Genes expressed in human tumor endothelium. Science 2000, 289(5482):1197-1202. 10.1126/science.289.5482.1197, 10947988.
10. MacFadyen J, Savage K, Wienke D, Isacke CM. Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development. Gene Exp Patterns 2007, 7(3):363-369.
11. MacFadyen JR, Haworth O, Roberston D, Hardie D, Webster MT, Morris HR, Panico M, Sutton-Smith M, Dell A, van der Geer P, Wienke D, Buckley CD, Isacke CM. Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett 2005, 579(12):2569-2575. 10.1016/j.febslet.2005.03.071, 15862292.
12. Simonavicius N, Robertson D, Bax DA, Jones C, Huijbers IJ, Isacke CM. Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol 2008, 21(3):308-315. 10.1038/modpathol.3801006, 18192970.
13. Christian S, Winkler R, Helfrich I, Boos AM, Besemfelder E, Schadendorf D, Augustin HG. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. Am J Pathol 2008, 172(2):486-494. 10.2353/ajpath.2008.070623, 2312374, 18187565.
14. Tomkowicz B, Rybinski K, Foley B, Ebel W, Kline B, Routhier E, Sass P, Nicolaides NC, Grasso L, Zhou Y. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. Proc Natl Acad Sci USA 2007, 104(46):17965-17970. 10.1073/pnas.0705647104, 2084280, 17986615.
15. Nanda A, Karim B, Peng Z, Liu G, Qiu W, Gan C, Vogelstein B, St Croix B, Kinzler KW, Huso DL. Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors. Proc Natl Acad Sci USA 2006, 103(9):3351-3356. 10.1073/pnas.0511306103, 1413931, 16492758.
16. Pachkoria K, Zhang H, Adell G, Jarlsfelt I, Sun XF. Cox-2 expression in rectal cancer patients with or without preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63(3):739-744. 10.1016/j.ijrobp.2005.02.031, 16199309.
17. Pfeifer D, Gao J, Adell G, Sun XF. Expression of the p73 protein in rectal cancers with or without preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2006, 65(4):1143-1148. 10.1016/j.ijrobp.2006.02.028, 16750334.
18. Wallin A, Svanvik J, Adell G, Sun XF. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2006, 65(2):452-458. 10.1016/j.ijrobp.2005.12.043, 16626893.
19. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 2001, 61(18):6649-6655.
20. Rmali KA, Puntis MC, Jiang WG. Prognostic values of tumor endothelial markers in patients with colorectal cancer. World J Gastroenterol 2005, 11(9):1283-1286.
21. Davies G, Cunnick GH, Mansel RE, Mason MD, Jiang WG. Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis 2004, 21(1):31-37. 10.1023/B:CLIN.0000017168.83616.d0, 15065600.
22. Brady J, Neal J, Sadakar N, Gasque P. Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors. J Neuropathol Exp Neurol 2004, 63(12):1274-1283.
23. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995, 55(17):3785-3789.
24. Zhang H, Sun XF. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am J Gastroenterol 2002, 97(4):1037-1041. 10.1111/j.1572-0241.2002.05625.x, 12003384.
25. Sun XF. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma. Clin Cancer Res 2002, 8(1):165-170.
26. Fiordalisi JJ, Keller PJ, Cox AD. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res 2006, 66(6):3153-3161. 10.1158/0008-5472.CAN-05-3116, 16540666.
27. Adell G, Sun XF, Stål O, Klintenberg C, Sjödahl R, Nordenskjöld B. p53 status: An indicator for the effect of preoperative radiotherapy of rectal cancer. Radiother Oncol 1999, 51(2):169-174. 10.1016/S0167-8140(99)00041-9, 10435809.
28. Pheifer D, Wallin A, Holmlund B, Sun XF. Protein expression following gamma-irradiation relevant to growth arrest and apoptosis in colon cancer cells. J Cancer Res Clin Oncol 2009, 135(11):1583-1592. 10.1007/s00432-009-0606-4, 19504123.
29. Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 2000, 60(5):1254-1260.
30. Salomoni P, Dyer MJ. Delta N-p73: the enemy within. Cell Death Differ 2005, 12(12):1553-1554. 10.1038/sj.cdd.4401802, 17694096.
31. Bhowmick NA, Moses HL. Tumor-stroma interactions. Curr Opin Genet Dev 2005, 15(1):97-101. 10.1016/j.gde.2004.12.003, 2819733, 15661539.
32. Huang HC, Hu CH, Tang MC, Wang WS, Chen PM, Su Y. Thymosin β4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase. Oncogene 2007, 26(19):2781-2790. 10.1038/sj.onc.1210078, 17072345.
33. Gao J, Arbman G, Reader A, Sun XF. Expression of PINCH protein is an independent prognostic factor in colorectal cancer patients. Neoplasia 2004, 6(6):796-801. 10.1593/neo.04304, 1531683, 15720806.
34. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 2003, 111(9):1287-1295. 154450, 12727920.